Barclays now sees two Fed cuts this year, says jumbo Fed cuts ’very unlikely’
Investing.com - OpGen reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
OpGen announced earnings per share of $-0.300 on revenue of $448.71K. Analysts polled by Investing.com EPS of $-0.130 on revenue of $1.55M.
OpGen 's are down 53.92% and is trading at $0.185 , still down 89.43% from its 52 week high of $1.75 set on Friday, November 12, 2021.
OpGen follows other major Healthcare sector earnings this month
OpGen's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar